All this work supports the conclusion that the over-expression of PREX2 can increase PI3K-dependent tumor growth (Fine et al., 2009), and that mutated PREX2 promotes tumorigenesis by increasing RAC-dependent invasiveness (Mense et al., 2015). The gene discussed is AKT1; the disease is neoplasm.